Document Detail


The effect of injected RGD modified alginate on angiogenesis and left ventricular function in a chronic rat infarct model.
MedLine Citation:
PMID:  19010528     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Congestive heart failure (CHF) is a chronic disease with a high mortality rate. Managing CHF patients has been one of the most severe health care problems for years. Scaffold materials have been predominantly investigated in acute myocardial infarction (MI) studies and have shown promising improvement in LV function. In this study we examined whether surface modification of a biomaterial can influence the myocardial microenvironment and improve myocardial function in a rodent model of ischemic cardiomyopathy. In vitro cell culture and in vivo rat studies were performed. RGD peptides conjugated to alginate improved human umbilical vein endothelial cell (HUVEC) proliferation and adhesion when compared to a non-modified alginate group. Injection of the alginate hydrogel into the infarct area of rats 5 weeks post-MI demonstrated that both modified and non-modified alginate improve heart function, while LV function in the control group deteriorated. Both the RGD modified alginate and non-modified alginate increased the arteriole density compared to control, with the RGD modified alginate having the greatest angiogenic response. These results suggest that in situ use of modified polymers may influence the tissue microenvironment and serve as a potential therapeutic agent for patients with chronic heart failure.
Authors:
Jiashing Yu; Yiping Gu; Kim T Du; Shirley Mihardja; Richard E Sievers; Randall J Lee
Related Documents :
9070168 - Angiotensin-converting enzyme inhibition in myocardial infarction--part 1: clinical data.
12891208 - Quantitative clinical assessment of chronic anterior myocardial infarction with delayed...
18837278 - Exploring the meaning of recovery following myocardial infarction.
19801148 - Triglycerides and non-high-density lipoprotein cholesterol and the incidence of cardiov...
22037388 - Additive value of severe diastolic dysfunction and contractile reserve in the identific...
7954768 - Intravascular ultrasound imaging after excimer laser angioplasty.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2008-11-17
Journal Detail:
Title:  Biomaterials     Volume:  30     ISSN:  1878-5905     ISO Abbreviation:  Biomaterials     Publication Date:  2009 Feb 
Date Detail:
Created Date:  2008-12-22     Completed Date:  2009-04-20     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8100316     Medline TA:  Biomaterials     Country:  England    
Other Details:
Languages:  eng     Pagination:  751-6     Citation Subset:  IM    
Affiliation:
University of California Berkeley and University of California San Francisco Joint Bioengineering Graduate Group, Berkeley/San Francisco, CA, United States.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Alginates / pharmacology*
Animals
Cell Adhesion / drug effects
Cell Proliferation / drug effects
Cells, Cultured
Disease Models, Animal
Female
Glucuronic Acid / pharmacology
Hexuronic Acids / pharmacology
Humans
Myocardial Infarction / drug therapy
Oligopeptides / chemistry*
Rats
Rats, Sprague-Dawley
Ventricular Function, Left / drug effects*
Ventricular Remodeling / drug effects
Chemical
Reg. No./Substance:
0/Alginates; 0/Hexuronic Acids; 0/Oligopeptides; 576-37-4/Glucuronic Acid; 9005-32-7/alginic acid; 99896-85-2/arginyl-glycyl-aspartic acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Inequalities in healthy life years in the 25 countries of the European Union in 2005: a cross-nation...
Next Document:  The effect of RGD density on osteoblast and endothelial cell behavior on RGD-grafted polyethylene te...